These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8578829)

  • 41. Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.
    Behr C; Sarthou JL; Rogier C; Trape JF; Dat MH; Michel JC; Aribot G; Dieye A; Claverie JM; Druihle P
    J Immunol; 1992 Nov; 149(10):3321-30. PubMed ID: 1431109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
    Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
    Das P; Grewal JS; Mahajan B; Chauhan VS
    Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
    Amante FH; Crewther PE; Anders RF; Good MF
    J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues.
    Sharma P; Kumar A; Singh B; Bharadwaj A; Sailaja VN; Adak T; Kushwaha A; Malhotra P; Chauhan VS
    Infect Immun; 1998 Jun; 66(6):2895-904. PubMed ID: 9596765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
    Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
    Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
    Balam S; Jafarshad A; Servis C; Frank G; Reed S; Pink R; Druilhe P; Spertini F; Corradin G
    Vaccine; 2016 Mar; 34(13):1566-1574. PubMed ID: 26874325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332.
    Ahlborg N; Sterky F; Haddad D; Perlmann P; Nygren PA; Andersson R; Berzins K
    Mol Immunol; 1997 Apr; 34(5):379-89. PubMed ID: 9293771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epitopes of the Plasmodium falciparum clustered-asparagine-rich protein (CARP) recognized by human T-cells and antibodies.
    Wahlgren M; Bejarano MT; Troye-Blomberg M; Perlmann P; Riley E; Greenwood BM; Patarroyo ME; Gonzales CI; Martinez A
    Parasite Immunol; 1991 Nov; 13(6):681-94. PubMed ID: 1725821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.
    Del Giudice G; Tougne C; Louis JA; Lambert PH; Bianchi E; Bonelli F; Chiappinelli L; Pessi A
    Eur J Immunol; 1990 Jul; 20(7):1619-22. PubMed ID: 2201549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary and secondary responses to (NANP) peptides by Plasmodium falciparum sporozoites in various strains of mice.
    Del Giudice G; Cheng Q; Mazier D; Meuwissen JH; Grau GE; Corradin G; Pessi A; Verdini AS; Lambert PH
    Scand J Immunol; 1989 May; 29(5):555-62. PubMed ID: 2471257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation.
    Ahlborg N; Nardin EH; Perlmann P; Berzins K; Andersson R
    Vaccine; 1998 Jan; 16(1):38-44. PubMed ID: 9607007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune response in mouse and malaria-exposed humans to peptides derived from Pf11-1, a highly repetitive megadalton protein of Plasmodium falciparum.
    Scherf A; Behr C; Sarthou JL; Pla M; Rogier C; Trape JF; da Silva LP; Dubois P
    Eur J Immunol; 1993 Jul; 23(7):1574-81. PubMed ID: 7686855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
    Good MF; Branigan J; Smith G; Houghten RA
    Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.
    Rzepczyk CM; Csurhes PA; Saul AJ; Jones GL; Dyer S; Chee D; Goss N; Irving DO
    J Immunol; 1992 Feb; 148(4):1197-204. PubMed ID: 1371134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T- and B-cell responses of malaria immune individuals to synthetic peptides corresponding to non-repeat sequences in the N-terminal region of the Plasmodium falciparum antigen Pf155/RESA.
    Kulane A; Siddique AB; Perlmann H; Ahlborg N; Roussilhon C; Tall A; Dieye A; Perlmann P; Troye-Blomberg M
    Acta Trop; 1997 Oct; 68(1):37-51. PubMed ID: 9352001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.